Video
Video course abdominal ultrasound
Right liver lobe, 3 levels
Author: Prof. Dr. Christoph F. Dietrich, Caritas Krankenhaus Bad Mergentheim.
© 2015 Falk Foundation e.V., Freiburg. All rights reserved.
Please switch on your loudspeakers!
Link to Falk Mediacenter:
http://media.falkfoundation.de/index.php?id=121&L=1
Link to the video directly:
http://media.drfalkpharma.de/fileadmin/media/06_Liver_Right_liver_lobe_3_levels_ENG.mp4
Preview images:
580 x 325 pixels (with arrow)
http://www.drfalkpharma.com/fileadmin/media/newsletter/Logos/Vorschau_Sono_Clip06_580P.jpg
580 x 325 pixels (without arrow)
http://www.drfalkpharma.com/fileadmin/media/newsletter/Logos/Vorschau_Sono_Clip06_580.jpg
Latest research in brief:
Description field (to be displayed at the end of the structural element):
Bowel
http://www.drfalkpharma.com/fileadmin/media/logos_falk/abstracts/Falk-Darm.png
Text:
Böhn L et al, Gastroenterology. 2015;149(6):1399–1407.e2
Dietary approaches for irritable bowel syndrome: A diet low in FODMAP reduces symptoms as well as traditional dietary advice (regular meal pattern, avoidance of fat, insoluble fibers, caffeine, and gas-producing foods).
Link:
http://www.drfalkpharma.com/index.php?L=1&id=20376#30591
Text:
Khanna R et al, Lancet. 2015;386(10006):1825–34
Therapy algorithms for Crohn’s disease: Early combined immunosuppression (antimetabolite plus TNF antagonist) is not superior to conventional therapy in controlling disease activity, but results in reduced rates of disease-related complications including operations and hospital admissions.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=20376#c30592
Text:
Baron JA et al, N Engl J Med. 2015;373(16):1519–30
Prevention of colorectal adenomas: Daily supplementation of vitamin D3 (1000 IU), calcium (1200 mg) or both after removal of adenomas does not reduce the risk of recurrent colorectal adenomas over a period of 3–5 years.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=20376#c30593
Liver
Biliary Tracts
http://www.drfalkpharma.com/fileadmin/media/logos_falk/abstracts/Falk-Leber.png
Text:
Roth D et al, Lancet. 2015;386(10003):1537–45
Hepatitis C: In patients with chronic kidney disease stage 4–5 (including patients on hemodialysis) and hepatitis C virus genotype 1, once daily grazoprevir plus elbasvir is well tolerated and highly efficient (sustained virological response rate 99%).
Link:
http://www.drfalkpharma.com/index.php?L=1&id=20376#c30594
Text:
van Meer S et al, J Hepatol. 2015;63(5):1156–63
Hepatocellular carcinoma (HCC): The benefit of surveillance for HCC is controversial. A Dutch study now demonstrated that surveillance for HCC is associated with smaller tumor size and earlier tumor stage at HCC diagnosis, impacts therapeutic strategy and is an independent predictor of survival.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=20376#c30595
Text:
Kirstein MM et al, Hepatology. 2015;62(5):1524–35
Autoimmune hepatitis: Diagnosis at an age < 18 years, histological presence of cirrhosis at diagnosis, and detection of SLA/LP antibodies are main risk factors for a poor short and long-term outcome of autoimmune hepatitis. Positivity for DRB1-04:01, in contrast, is associated with a favorable clinical course.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=20376#c30596
Oesophagus
Stomach
Duodenum
http://www.drfalkpharma.com/fileadmin/media/logos_falk/abstracts/Falk-Magen.png
Text:
Moawad FJ et al, Gut. 2015;64(12):1874–80
Barrett’s esophagus length is established at the time of initial endoscopy and does not change over time.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=20376#c30597
Text:
Choung RS et al, Clin Gastroenterol Hepatol. 2015;13(11):1937–43
Symptoms indicative of functional gastrointestinal disorders and seropositive celiac disease are relatively common in a U.S. white community. However, testing for celiac disease in patients with irritable bowel syndrome may not result in improved detection of patients with celiac disease.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=20376#c30598
Text:
Zeng M et al, Lancet. 2015;386(10002):1457–64
Vaccination against Helicobacter pylori: An oral recombinant vaccine was effective and safe in a randomized placebo-controlled phase III trial of previously uninfected children and resulted in immunogenic responses in 71,8% of study participants.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=20376#c30599
Pancreas
http://www.drfalkpharma.com/fileadmin/media/logos_falk/abstracts/Falk-Pankreas.png
Text:
da Costa DW et al, Lancet. 2015;386(10000):1261–8
Biliary pancreatitis: Compared with interval cholecystectomy, same-admission cholecystectomy reduces the rate of recurrent biliary complications with a very low risk of surgery-associated complications.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=20376#c30600
Falk Symposia
Workshop
Communications and System Relevance in Liver Damage and Regeneration
Bild:
http://www.drfalkpharma.com/fileadmin/media/newsletter/falk_workshop.gif
Text:
January 21 – 22, 2016, Düsseldorf, Germany
Building 23.01, Hörsaal 3D, Heinrich-Heine University, Universitätsstr. 1, 40225 Düsseldorf, Germany
Link1:
Link2:
Link für Online-Anmeldung:
http://events.falkfoundation.com/index.php?id=42&L=1
Symposium 201
Gut-Liver Interactions: From IBD to NASH
Bild:
http://www.drfalkpharma.com/fileadmin/media/newsletter/symposium.gif
Text:
March 11 – 12, 2016, Innsbruck, Austria
Congress Innsbruck, Rennweg 3, 6020 Innsbruck, Austria
Link1:
Link2:
Link für Online-Anmeldung:
http://events.falkfoundation.com/index.php?id=205&L=1
Symposium 202
Evolving Therapies in Clinical Practice in IBD
Bild:
http://www.drfalkpharma.com/fileadmin/media/newsletter/symposium.gif
Text:
April 29 – 30, 2016, Prague, Czech Republic
Hilton Prague, Pobrezni 1, 18600 Prague 08, Czech Republic
Link1:
Link2:
Link für Online-Anmeldung:
http://events.falkfoundation.com/index.php?id=206&L=1
Current Falk literature:
Microscopic colitis – Collagenous and lymphocytic colitis
Author: A. Tromm
(50 pages)
Revised edition 2015
BU6e
Picture:
PDF:
Order by email (Please replace text by your email address):